Search Results - "Hernandez, Ana Lluch"

Inflammatory breast carcinoma : pathological or clinical entity? by RUIZ SIMON, Amparo, CLIMENT DURAN, Miguel Angel, LLUCH HERNANDEZ, Ana, LLOMBART CUSSAC, Antonio, MOYA SAHORI, Vicente, FERNANDEZ-MARTOS, Carlos, GUILLEM PORTA, Vicente

“…Inflammatory breast carcinoma (IBC) diagnosis is usually based in the presence of typical clinical symptoms (redness and edema in more than 2/3 of the breast),…”
Get full text

An Overview of Letrozole in Postmenopausal Women with Hormone-Responsive Breast Cancer by Barnadas, Agustí, Estévez, Laura G., Lluch-Hernández, Ana, Rodriguez-Lescure, Álvaro, Rodriguez-Sanchez, César, Sanchez-Rovira, Pedro

“…Third-generation aromatase inhibitors (AIs) have proven to be superior to tamoxifen in terms of time to disease progression in patients with hormone receptor…”
Get full text

Spanish Society of Medical Oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients by Carrato Mena, Alfredo, Paz-Ares Rodríguez, Luis, Rodríguez Lescure, Álvaro, Casas Fernández de Tejerina, Ana M., Díaz Rubio García, Eduardo, Pérez Segura, Pedro, Constenla Figueiras, Manuel, García Carbonero, Rocío, Gómez Codina, José, Lluch Hernández, Ana, Maroto Rey, José Pablo, Martín Jiménez, Miguel, Mayordomo Cámara, José Ignacio, Moreno Nogueira, José Andrés, Rueda Domínguez, Antonio

“…Neutropenia is a common complication of cancer chemotherapy. Colony-stimulating factors (CSF) may be used to avoid neutropenia-associated complications. The…”
Get full text

Abstract P3-17-05: Physicians’ attitudes and perceived barriers to adherence to national breast cancer clinical practice guidelines (BCCPG) in Mexico by Martinez-Cannon, Bertha Alejandra, Soto-Perez-de-Celis, Enrique, Valle-Solis, Aura A. Erazo, Salinas, Claudia Arce, Rocha, Enrique Bargallo, Piña, Veronica Bautista, Sanchez, Ma. Guadalupe Cervantes, Balcazar, Christian Haydee Flores, Tamburrino, Maria del Carmen Lara, Hernandez, Ana Lluch, Aziz, Antonio Maffuz, Sanchez, Victor Manuel Perez, Chacon, Adela Poitevin, Gonzalez, Efrain Salas, Torres, Laura Torrecillas, Valero, Vicente, Navarro, Yolanda Villaseñor, Sanchez, Jesus Cardenas

“…Background: Adherence to BCCPG improves clinical outcomes for patients with breast cancer. However, implementation of international BCCPG may not be feasible…”
Get full text

Abstract GS3-00: First results from a phase III randomized clinical trial of standard adjuvant endocrine therapy (ET) +/- chemotherapy (CT) in patients (pts) with 1-3 positive nodes, hormone receptor-positive (HR+) and HER2-negative (HER2-) breast cancer (BC) with recurrence score (RS) < 25: SWOG S1007 (RxPonder) by Kalinsky, Kevin, Barlow, William E, Meric-Bernstam, Funda, Gralow, Julie R, Albain, Kathy S, Hayes, Daniel, Lin, Nancy, Perez, Edith A, Goldstein, Lori J, Chia, Stephen, Dhesy-Thind, Subkhbinder, Rastogi, Priya, Alba, Emilio, Delaloge, Suzette, Martín, Miguel, Gil, Miguel Gil, Arce-Salinas, Claudia, Brain, Etienne, Park, In Hae, Pierga, Jean-Yves, Lluch, Ana Hernandez, Vasquez, Manuel Ramos, Borrego, Manuel Ruiz, Jung, Kyung Hae, Ferrero, Jean-Marc, Schott, Anne, Shak, Steve, Sharma, Priyanka, Lew, Danika L, Miao, Jieling, Tripathy, Debu, Hortobagyi, Gabriel, Pusztai, Lajos

“…Funding: Supported by National Cancer Institute grants U10CA180888, U10CA180819, U10CA180820, U10CA180821, U10CA180868, U10CA180863; and in part by Susan G…”
Get full text

Prospective evaluation of the conversion rate in the receptor status between primary breast cancer and metastasis: results from the GEICAM 2009-03 ConvertHER study by de Dueñas, Eduardo Martínez, Hernández, Ana Lluch, Zotano, Ángel Guerrero, Carrión, Ramón María Pérez, López-Muñiz, José Ignacio Chacón, Novoa, Silvia Antolín, Rodríguez, Ángela López, Fidalgo, José Alejandro Pérez, Lozano, Jaime Ferrer, Gasión, Octavio Burgués, Carrascal, Eva Carrasco, Capilla, Andrés Hernando, López-Barajas, Isabel Blancas, Mateu, Montserrat Muñoz, de Ceballos Reyna, María Helena López, Ferrando, Amparo Oltra, Jañez, Noelia Martínez, Ballerini, Vicente Carañana, Torres, Antonio Antón, Catalán, Gustavo, Sáenz, José Ángel García, Menjón, Salomón, González-Angulo, Ana María

“…The objective of this study was to determine the conversion rate of human epidermal growth factor receptor 2 (HER2), estrogen receptor (ER) and progesterone…”
Get full text

Dietary inflammatory index and breast cancer risk by menopausal status and histological subtype by Castello, Adela, Shivappa, Nitin, Ruiz, Amparo, Casas, Ana, Lluch Hernandez, Ana, Baena-Cañada, José Manuel, Antolin, Silvia, Sánchez Rovira, Pedro, Ramos Vazquez, Manuel, Garcia-Saenz, Jose Angel, Anton, Antonio, Munoz, Montserrat, de Juan, Ana, Jara-Sanchez, Carlos, Vioque, Jesus, Perez-Gomez, Beatriz, Hébert, James R., Lope, Virginia, Martin, Miguel, Pollan, Marina

“…Abstract only…”
Get full text

Plasma sequencing of ctDNA in early stage breast cancer as part of the screening process by Jimenez Rodriguez, Begona, Diaz Córdoba, Gema, Garrido Aranda, Alicia, Vicioso, Luis, Parrado, M Rosario Chica, de Luque, Vanessa, Lozano, Maria Jose, Moreno Ros, Mar, Bellagarza, Estefania, Hernando, Cristina, Bermejo, Begona, Lluch Hernandez, Ana, Álvarez, Martina, Jones, Frederick S., Nocon, Annette, Ryder, Matthew B., Fredebohm, Johannes, Mehnert, Daniel, Holtrup, Frank, Alba, Emilio

“…Abstract only…”
Get full text

Genomic alterations driving breast cancer (BC) metastases and their relationship with the subtype switch in the GEICAM ConvertHER study by Albanell, Joan, Gonzalez, Abel, Gonzalez-Angulo, Ana M., Eterovic, Agda Karina, Martinez-De Duenas, Eduardo, Zheng, Xiaofeng, Guerrero, Angel, Liu, Shuying, Pérez-Carrión, Ramon, Chen, Ken, Chacon, Jose Ignacio, Mills, Gordon B., Antolín Novoa, Silvia, Blancas, Isabel, Sanchez-Arago, Maria, Carrasco, Eva Maria, Caballero, Rosalia, Rojo, Federico, Meric-Bernstam, Funda, Lluch Hernandez, Ana

“…Abstract only 1017 Background: To understand the mechanisms underlying the evolution of tumors in the process of metastasis, we studied 61 paired…”
Get full text

El camino a la igualdad real: La presencia de la mujer en el ámbito académico by Ana Lluch Hernández

“…La posición de la mujer dentro del ámbito científico ha sufrido una importante evolución en los últimos años, especialmente en la última década con la…”
Get full text

Nueva era en el combate contra el cáncer: Evolución y cáncer: progreso y tratamiento de tumores by Ana Lluch Hernández, José Alejandro Pérez-Fidalgo, Paloma Martín Martorell

“…La oncohematología ha asistido en las últimas décadas a importantes avances en el tratamiento y supervivencia. La toxicidad derivada de la quimioterapia…”
Get full text

Foreword by Hernández, Ana Lluch, Meliá, Cristina Hernando

Get full text

Foreword by Hernández, Ana Lluch, Meliá, Cristina Hernando

Get full text

Foreword by Ana Lluch Hernández, Cristina Hernando Meliá

“…The evolution of breast cancer from an early stage to metastatic disease is highly complex and is associated with greater heterogeneity, altered gene…”
Get full text

Foreword by Ana Lluch Hernández, Cristina Hernando Meliá

“…The evolution of breast cancer from an early stage to metastatic disease is highly complex and is associated with greater heterogeneity, altered gene…”
Get full text

Consenso mexicano de cáncer mamario. Manejo del cáncer de mama avanzado by Guadalupe Cervantes-Sánchez, Tania Hernández-Barragán, Fernando Aldaco-Sarvide, Claudia Arce-Salinas, Juan E. Bargalló-Rocha, Verónica Bautista-Piña, Mariana Chávez-MacGregor, Georgina Garnica-Jaliffe, Christian H. Flores-Balcázar, Ma. del Carmen Lara-Tamburrino, Ana Lluch-Hernández, Antonio Maffuz-Aziz, Perla Pérez, Víctor M. Pérez-Sánchez, Adela Poitevin-Chacón, Efraín Salas-González, Enrique Soto-Pérez-de-Celis, Laura Torrecillas-Torres, Vicente Valero-Castillo, Yolanda Villaseñor-Navarro, Jesús Cárdenas-Sánchez

“…El cáncer de mama es la neoplasia más frecuente y con mayor mortalidad en mujeres en todo el mundo. La décima actualización del Consenso Mexicano Sobre…”
Get full text

Consenso mexicano de cáncer mamario. Cuidados multidisciplinarios en cáncer de mama by Enrique Soto-Pérez-de-Celis, Dione Aguilar-y-Méndez, Silvia R. Allende-Pérez, Rosa Ma. Álvarez-Gómez, Verónica Cedillo-Compeán, Ma. Teresa de J. Cervantes-Díaz, Mariana Chávez-MacGregor, Mabelid Mabiani-Céspedes, Edith A. Monreal-Carrillo, Ma. Paulina Núñez-Martínez, Guadalupe E. Paredes-Rivera, Edith Rojas-Castillo, Sofía Saba-Cohén, Isabelle A. Timeus-Salvato, Emma L. Verastegui-Avilés, Silvia Vidal-Millán, Talia Wegman-Ostrosky, Claudia Arce-Salinas, Juan E. Bargalló-Rocha, Verónica Bautista-Piña, Guadalupe Cervantes-Sánchez, Christian H. Flores-Balcázar, Ma. del Carmen Lara-Tamburrino, Ana Lluch-Hernández, Antonio Maffuz-Aziz, Víctor M. Pérez-Sánchez, Adela Poitevin-Chacón, Efraín Salas-González, Laura Torrecillas-Torres, Vicente Valero-Castillo, Yolanda Villaseñor-Navarro, Jesús Cárdenas-Sánchez

“…El cáncer mamario impacta en diversas esferas de la vida del paciente y su entorno familiar y social. Se trata de una enfermedad compleja que requiere un…”
Get full text

Consenso mexicano de cáncer mamario. Manejo del cáncer de mama temprano by Juan E. Bargalló-Rocha, Sergio Aguilar-Villanueva, Carolina Ahumada-Pámanes, Claudia Arce-Salinas, Alethia Álvarez-Cano, Isaac Baley-Spindel, Verónica Bautista-Piña, Guadalupe Cervantes-Sánchez, Mariana Chávez-MacGregor, Nererida Esparza-Arias, Johnatan Figueroa-Padilla, Christian H. Flores-Balcázar, Sonia Ma. Flores-Moreno, Antonio Maffuz-Aziz, Federico Maldonado-Magos, Ma. del Carmen Lara-Tamburrino, Ana Lluch-Hernández, Sarina Navarro-Santiesteban, Víctor M. Pérez-Sánchez, Adela Poitevin-Chacón, Eva Ruvalcaba-Limón, Efraín Salas-González, Amelia Sarricolea-Puch, Enrique Soto-Pérez-de-Celis, Laura Torrecillas-Torres, Vicente Valero-Castillo, Yolanda Villaseñor-Navarro, Jesús Cárdenas-Sánchez

“…El cáncer mamario en estadios tempranos tiene un manejo local (quirúrgico y radioterapia) y sistémico específico. Este tipo de cáncer incluye el carcinoma…”
Get full text

Quantitative monoclonal antibody determination of estrogen and progesterone receptors in human breast cancer: correlation with the radioligand method by Jarque, F, Lluch, A, Vizcarra, E, Muñoz, M, Alberola, V, Garciá-Conde, J

“…To assess the possibility of substituting our routine method (dextran-coated charcoal, DCC) of determining estrogen (ER) and progesterone receptors (PR) for an…”
Get more information

Nuevos retos en el tratamiento y la investigación del cáncer de mama by Ana Lluch Hernández

“…La terapia contra el cáncer ha experimentado importantes avances que se han producido con una celeridad inusitada. El arsenal terapéutico se ha intensificado…”
Get full text